Park MK

References (3)

Title : The rs662 polymorphism of paraoxonase 1 affects the difference in the inhibition of butyrylcholinesterase activity by organophosphorus pesticides in human blood - Nam_2016_Int.J.Clin.Pharmacol.Ther_54_622
Author(s) : Nam DC , Ha YM , Park MK , Cho SK
Ref : Int J Clinical Pharmacology & Therapeutics , 54 :622 , 2016
Abstract :
PubMedSearch : Nam_2016_Int.J.Clin.Pharmacol.Ther_54_622
PubMedID: 27087156

Title : Multiple-dose pharmacokinetics and pharmacodynamics of evogliptin (DA-1229), a novel dipeptidyl peptidase IV inhibitor, in healthy volunteers - Gu_2014_Drug.Des.Devel.Ther_8_1709
Author(s) : Gu N , Park MK , Kim TE , Bahng MY , Lim KS , Cho SH , Yoon SH , Cho JY , Jang IJ , Yu KS
Ref : Drug Des Devel Ther , 8 :1709 , 2014
Abstract :
PubMedSearch : Gu_2014_Drug.Des.Devel.Ther_8_1709
PubMedID: 25336915

Title : Midazolam protects B35 neuroblastoma cells through Akt-phosphorylation in reactive oxygen species derived cellular injury - Chong_2012_Korean.J.Anesthesiol_62_166
Author(s) : Chong WS , Hyun CL , Park MK , Park JM , Song HO , Park T , Lim YS , Cho CK , Kang PS , Kwon HU
Ref : Korean J Anesthesiol , 62 :166 , 2012
Abstract :
PubMedSearch : Chong_2012_Korean.J.Anesthesiol_62_166
PubMedID: 22379573